Evidence mapPaperPMID 41399357Full record

ArticleMaterials today. Bio2025

Phlorizin-integrated magnetic pollen micromotors for diabetes complication management.

Minyu Zhou, Xinyuan Yang, Hongzheng Li, Luoran Shang

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Minyu ZhouThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325035, China.
Xinyuan YangShanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, The Shanghai Key Laboratory of Medical Epigenetics, The International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Hongzheng LiThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325035, China.
Luoran ShangThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325035, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phlorizin (PHZ) is a compound naturally found in apples, hawthorns and other plants, which shows potential in treating diabetes and its complications. However, its intestinal stability and precise targeted release ability remain challenging. Herein, we proposed a PHZ-integrated magnetic pollen micromotor for the treatment of diabetes combined with intestinal inflammation, which can well solve these problems and achieve the goal of effective drug release. We used porous pollen to load PHZ and then wrapped it with a calcium alginate (CaAlg) shell. Additionally, Fe

Indexed as

Diabetes mellitusDrug deliveryIntestinal inflammationMicromotorsPhlorizinPollen

Identifiers

PMID41399357
PMCPMC12702401

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.